IPONATIC
LIVE

Serial Number

79307749

Owner

Sansure Biotech Inc.

Attorney

Yue (Robert) Xu

Filing Date

Oct 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IPONATIC Trademark

Serial Number: 79307749 • Registration: 6585566

IPONATIC is a trademark filed by Sansure Biotech Inc. on October 29, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Sansure Biotech Inc. (10 trademarks)

No. 680, Lusong Road,

Entity Type: 03

Trademark Details

Filing Date

October 29, 2020

Registration Date

December 14, 2021

Published for Opposition

September 28, 2021

Goods & Services

Injectable pharmaceuticals for treatment of anaphylactic reactions; biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; antibiotic tablets; allergy tablets; mineral, vitamin, or nutritionally enhanced water for medical purposes; medicated water for the treatment of illnesses attributed to insufficient cellular energy; medicated water for the treatment of allergies, cough, cold, flu, headache, pain; medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; medicated water for the treatment of pain, nausea and muscle spasms; medicated water-based solutions for treating skin infections and skin conditions; medicated water for the treatment of gastrointestinal disorders; antibiotic ointments; anti-inflammatory ointments; medicated ointments for treating dermatological conditions; chinese medicine nostrum in the nature of natural remedy preparation, namely, medicinal herbs; diagnostic kits for medical diagnostic purposes comprising medical diagnostic reagents for use in disease testing, health monitoring and predictive and preventive medicine in the fields of detecting immune system and respiratory system diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; purified biochemicals, namely, protein arrays, enzymes, and fluorescent dyes for use as reagents in medical diagnostic applications; biological preparations for pharmaceutical purposes for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological, oncological, hematological, tissue and organ transplantation, ophthalmological and gastroenterological disorders; biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological, oncological, hematological, tissue and organ transplantation, ophthalmological and gastroenterological disorders; chemical reagents for medical or veterinary purposes; reagents for medical use; medical diagnostic reagents for genetic testing; medical diagnostic reagents; enzyme preparations for medical purposes; diagnostic biomarker reagents for medical purposes; reagent paper for medical or veterinary purposes; diagnostic preparations for veterinary purposes; chemical preparations for the diagnosis of pregnancy; preparations for detecting genetic predispositions for medical purposes; immunoassay reagents for medical use; genetic identity tests comprised of reagents for medical purposes; preparations for detecting mutation in prion genes for medical purposes; cultures of microorganisms for medical or veterinary use

Surgical apparatus and instruments; dropping pipettes for medical purposes; medical devices in the nature of a nucleic acid analyzer for medical diagnosis; diagnostic apparatus for medical and veterinary purposes, in particular for detecting target nucleic acid molecules in a sample, in particular in a patient sample; medical apparatus for purifying nucleic acids; medical nucleic acid amplification and detection apparatus; medical equipment, namely, devices for bioanalysis of pathogens incorporating cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection for medical diagnostic purposes; medical laboratory instruments for diagnostic use and medical diagnostic instruments, namely, nucleic acid sequencers and synthesizers, genetic analyzers, fragment analyzers, electrophoresis machines, linkage analyzers, genetic mappers, thermal cyclers, cytometer, chemical reaction mixture containment apparatus and structural parts thereof, protein and peptide synthesizers, mass spectrometer and chromatograph, high-throughput instruments for preparation of nucleic acid samples; X-ray diagnostic apparatus; X-ray apparatus for medical use; lasers for medical purposes; radiotherapy apparatus; physiotherapy apparatus, namely, body rehabilitation apparatus for medical use; orthopaedic belts; apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for cavitation detecting, and apparatus for imaging analysis; diagnostic apparatus for medical purposes comprising diagnostic imaging apparatus, displays, monitors and recorded computer operating software therefor sold as a unit; digital hearing aids; analysers for bacterial identification for medical purposes; apparatus for DNA and RNA testing for medical purposes; blood testing apparatus

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 28, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 2, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 2, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 14, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 14, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 28, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 28, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 8, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2021 TROA
REFUSAL PROCESSED BY IB
May 12, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 15, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 14, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 13, 2021 MAFR
ASSIGNED TO EXAMINER
Apr 8, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 6, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 1, 2021 REPR